Sang Gyu Lee

Mr. Sang Gyu Lee

Department of Dermatology & Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YLYoung In Lee
Young In Lee
SLSang Gyu Lee
Sang Gyu Lee
IJInhee Jung
Inhee Jung
JSJangmi Suk
Jangmi Suk
MLMun-Hoe Lee
Mun-Hoe Lee
JLJu Hee Lee Lee
Ju Hee Lee Lee
The glycation process has been recognized as one of the critical parameters that accelerate signs of skin aging, especially in skin exposed to environment factors, such as ultraviolet radiation. Although previous studies showed the anti-inflammatory and antiaging properties of the hydrolyzed collagen tripeptide (CTP), its exact mechanism is not fully understood. Therefore, in this study, we sought to investigate the effect of a topical CTP on facial skin. Our group designed a 4 week prospective, single-arm study of 22 Asian women who applied topical CTP. We observed significant improvements in skin wrinkles, elasticity, and density with a reduction in skin accumulation of advanced glycated end products (AGEs) at week 4 without any adverse effects. The in vitro study revealed a preventive effect of the topical CTP on the accumulation of AGEs, denatured collagen production, and reactive oxygen species in dermal fibroblasts. Moreover, treatment with the CTP decreased induction of matrix metalloproteinases while increasing the collagen 1 level. These results suggest that the application of a topical CTP might improve clinical aging phenotypes via the inhibition of glycation and oxidative stress, leading to a delay in cellular aging.

1 January 2023 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
JKJemin Kim
Jemin Kim
SLSang Gyu Lee
Sang Gyu Lee
SCSooyeon Choi
Sooyeon Choi
JLJoohee Lee
Joohee Lee
YLYoung In Lee
Young In Lee
JLJu Hee Lee Lee
Ju Hee Lee Lee
Kim J, et al. Yonsei Med J. 2023 Dec;64(12):721-729. https://doi.org/10.3349/ymj.2023.0234

29 August 2023 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
SLSang Gyu Lee
Sang Gyu Lee
JKJihee Kim
Jihee Kim
YLYoung In Lee
Young In Lee
JKJemin Kim
Jemin Kim
YCYe Seul Choi
Ye Seul Choi
JLJu Hee Lee Lee
Ju Hee Lee Lee

Verified
Journal Article
Open access
PDF file
YLYoung In Lee
Young In Lee
SLSang Gyu Lee
Sang Gyu Lee
JKJemin Kim
Jemin Kim
SCSooyeon Choi
Sooyeon Choi
IJInhee Jung
Inhee Jung
JLJu Hee Lee Lee
Ju Hee Lee Lee
Dry and eczema-prone skin conditions such as atopic dermatitis and xerotic eczema primarily indicate an impaired skin barrier function, which leads to chronic pruritus. Here, we investigated the effects of a novel emollient containing H.ECMTM liposome, which contains a soluble proteoglycan in combination with hydrolyzed collagen and hyaluronic acid. A prospective, single-arm study was conducted on 25 participants with mild atopic dermatitis or dry skin to assess the hydration and anti-inflammatory effect of the novel emollient applied daily over four weeks. All efficacy parameters, including itching severity, transepidermal water loss, and skin hydration, improved significantly after four weeks. The in vitro and ex vivo studies confirmed the restoration of the skin’s barrier function. The study revealed the clinical and laboratory efficacy of H.ECMTM liposome in reducing itching and improving the skin’s barrier integrity. Thus, the use of H.ECMTM liposome can be considered a therapeutic option for dry and eczema-prone skin.

1 January 2024 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
YLYoung In Lee
Young In Lee
SLSang Gyu Lee
Sang Gyu Lee
SHSeoyoon Ham
Seoyoon Ham
IJInhee Jung
Inhee Jung
JSJangmi Suk
Jangmi Suk
JLJu Hee Lee Lee
Ju Hee Lee Lee
Lee YI, et al. Yonsei Med J. 2024 Feb;65(2):98-107. https://doi.org/10.3349/ymj.2023.0125

28 February 2024 in Skin Research and Technology
Verified
Journal Article
Open access
SLSang Gyu Lee
Sang Gyu Lee
SHSeoyoon Ham
Seoyoon Ham
JLJoohee Lee
Joohee Lee
YJYujin Jang
Yujin Jang
JSJangmi Suk
Jangmi Suk
JLJu Hee Lee Lee
Ju Hee Lee Lee
Background: Skin aging, characterized by the deterioration of skin density and elasticity, is a common concern among individuals seeking to maintain a youthful appearance. Zinc‐α2‐glycoprotein (ZAG) is secreted by various body fluids, and is associated with lipolysis and identified as an atopic dermatitis biomarker. This study evaluated the potential of ZAG peptides, which exert multiple benefits such as anti‐aging. Materials and Methods: We conducted a 4‐week clinical trial on patients with noticeable periorbital wrinkles ( n = 22) using a ZAG peptide‐containing product. The effects of the products on skin density, elasticity, and the depth of periorbital wrinkles were evaluated using Cutometer Dual MPA580, Ultrascan, and Antera 3D CS, respectively. The effect of ZAG peptides on UVB‐treated keratinocyte cells was evaluated in vitro to understand the mechanisms underlying its effects against impaired skin barrier function, collagen degradation, and senescence. In addition, the effects of ZAG peptides on cell viability and expression of aging and skin barrier‐related genes were assessed using cell counting kit assay and quantitative reverse transcription‐polymerase chain reaction, respectively. Results: The patients demonstrated improved skin density, elasticity, and reduced periorbital wrinkles. Further, more than 85% patients scored the product as satisfactory regarding anti‐aging effects. Furthermore, ZAG peptides reduced SA‐β‐gal staining, downregulated the senescence‐related genes, and upregulated the skin barrier function‐related genes in UVB‐irradiated keratinocyte cells. Conclusions: Our clinical and in vitro findings showed that ZAG peptides exert anti‐aging effects and improve skin barrier functions, suggesting their promising potential as therapeutic agents to combat skin aging and improve skin health.